Chaoyuan Huang
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
2-Hydroxy-3-Methylanthraquinone Suppresses Hepatocellular Carcinoma Progression by Blocking Annexin A5-Mediated Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling.
Journal: Chemical biology & drug design
Published: January 17, 2025
Retraction Note: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells.
Journal: Cellular & molecular biology letters
Published: December 30, 2024
Correction: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells.
Journal: Cellular & molecular biology letters
Published: April 04, 2023
Correction to: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells.
Journal: Cellular & molecular biology letters
Published: December 31, 2021
Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells.
Journal: Cellular & molecular biology letters
Published: October 21, 2020
Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma.
Journal: Digestive diseases and sciences
Published: February 06, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026